Sponsor Pipeline

Douglas Tremblay Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-12 NCT06159491
Pacritinib in CMML		 date change Completion pushed: 2027-07 -> 2028-01
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06159491 Pacritinib in CMML Chronic Myelomonocytic Leukemia Recruiting
Phase 1
NCT07320235 Imetelstat Combinations in Relapsed AML Relapsed Acute Myeloid Leukemia Recruiting
Disease Areas
Leukemia (2) Acute Myeloid Leukemia (AML) (1)
Get alerts when Douglas Tremblay's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free